Crees, Z., Ghobadi, A., Budde, E., Galal, A., Lin, C., Choi, D., Im, S., Jeong, H., Oh, A., Rettig, M., DiPersio, J. (2025). A Phase 1 study evaluating NT-I7 (efineptakin alfa), a long-acting human IL-7, post-tisagenlecleucel (tisa-cel), post-axicabtagene ciloleucel (axi-cel), or post-lisocabtagene maraleucel (liso-cel) in Relapsed/Refractory large B-cell lymphoma. Blood. https://doi.org/10.1182/blood-2025-926